ARCHIVES

Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

Peter Boyle Elected IARC Director

May 23, 2003

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

NCI Staff Recommends Moving Cooperative Groups Into DCT, Increase Funding, Switch Emphasis

July 4, 1975

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

Seer Gets Concept Approve For Five More Years From Ad Hoc Committee Since Two PLs Are DCPC Board Members

February 3, 1984

FDA, Companies Fail To Collect COI Forms, Report Says

January 16, 2009